GABAergic dynamics in thalamocortical circuits: Insights into absence seizures and hyperinhibition
Mohammad J Eslamizade1, Ali Dabbagh2, Fariba Karimzadeh3
1Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Neuroscience, Carleton University, Ottawa, Canada.
Abstract:
Over the last decade, experimental and clinical evidence has shaped the excitation/inhibition imbalance doctrine, which serves as our contemporary understanding of the mechanisms underlying various epilepsies. In addition, emerging findings have highlighted the peculiar role of γ-aminobutyric acid (GABA), the brain's main inhibitory neurotransmitter, as an underappreciated factor in hyperexcitation disorders such as epilepsy. Intriguingly, the unique neuroanatomy and synaptic physiology of thalamocortical (TC) circuits have made this axis a distinctive field of study. In this review, we focus on the current literature that explores the detailed structure of the GABAergic system in TC circuits under both normal conditions and absence seizures. Augmented excitability of TC neurons as well as cortical somatosensory neurons due to differential activity of various GABAergic neurons and synapses contributes to hyperoscillatory circuits in absence seizures. Furthermore, subtle yet significant differential expression of GABA receptor subunits in the thalamus and somatosensory cortex plays crucial roles in the pathophysiology of absence seizures. Convincing evidence also underscores the pivotal importance of the lower expression of GABA transporters, particularly in astrocytes, which increases synaptic concentration of GABA and promotes persistent tonic inhibition in the thalamus. This, in turn, creates a priming membrane potential that facilitates activation of transient (T)-type calcium channels, thereby increasing the excitability of TC neurons. In summary, this review accentuates hyperinhibition as a leading pathophysiology of absence seizures. Thus, there is a pressing need to develop targeted pharmacologic interventions or precision medicine approaches to treat absence seizures and potentially other TC related disorders.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Overview of Synapses
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...


